menu
    • menu

    Company profile for Tyme Technologies

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TYME is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, our therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress ...
    TYME is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, our therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tyme TechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    17 State Street, 7th Floor New York, NY 10004
    Telephone
    Telephone
    212-461-2315
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tymeinc.com/home/default.aspx
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tymeinc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tyme_inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
    Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders

    20 Sep 2022

    // SEEKING ALPHA

    https://seekingalpha.com/article/4542012-syros-pharmaceuticals-a-major-vote-of-confidence-from-insiders

    SEEKING ALPHA
    20 Sep 2022
    Share Share
    Syros and Tyme Technologies Announce Stockholder Approval of Merger
    Syros and Tyme Technologies Announce Stockholder Approval of Merger

    15 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220915005978/en

    BUSINESSWIRE
    15 Sep 2022
    Share Share
    TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS
    TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS

    07 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/07/2511446/0/en/TYME-Technologies-Inc-Announces-Proxy-Advisory-Firms-Glass-Lewis-and-ISS-Recommend-Stockholders-Vote-FOR-Proposed-Merger-of-Syros-and-Tyme.html

    GLOBENEWSWIRE
    07 Sep 2022
    Share Share
    Syros Reports Second Quarter 2022 Financial Results
    Syros Reports Second Quarter 2022 Financial Results

    09 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220809005360/en

    BUSINESSWIRE
    09 Aug 2022
    Share Share
    Syros buys Tyme, securing $190M to extend cash runway into 2025
    Syros buys Tyme, securing $190M to extend cash runway into 2025

    06 Jul 2022

    // Nick Paul Taylor FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/buying-tyme-syros-inks-190m-merger-flagship-backed-financing-extend-cash-runway-2025

    Nick Paul Taylor FIERCEBIOTECH
    06 Jul 2022
    Share Share
    TYME Technologies Reports Q4 and Fiscal FY 2022 Financial Results
    TYME Technologies Reports Q4 and Fiscal FY 2022 Financial Results

    25 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/25/2450166/0/en/TYME-Technologies-Inc-Reports-Fourth-Fiscal-Quarter-and-Full-Year-2022-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    25 May 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search